Ignite Creation Date:
2024-05-06 @ 6:46 PM
Last Modification Date:
2024-10-26 @ 2:55 PM
Study NCT ID:
NCT05789901
Status:
RECRUITING
Last Update Posted:
2024-03-06
First Post:
2023-03-14
Brief Title:
The MARVIN Chatbots to Provide Information for Different Health Conditions
Sponsor:
McGill University Health CentreResearch Institute of the McGill University Health Centre
Organization:
McGill University Health CentreResearch Institute of the McGill University Health Centre
Study Overview
Official Title:
A Master Research Protocol to Adapt and Evaluate an Artificial Intelligence Based Conversational Agent to Provide Information for Different Health Conditions the MARVIN Chatbots
Status:
RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This research is a continuation of a usability study with the MARVIN chatbot The investigators aim to adapt the MARVIN chatbot to open it to other health domains eg breast cancer and populations eg pharmacists Therefore this protocol constitutes a master research protocol that will englobe different research projects with individual chatbots The investigators adopt an adaptive platform trial design which will allow flexibility in handling multiple interventions adapted to different populations while retaining the characteristics of a platform trial design allowing early withdrawal of ineffective trial arms based on interim data implementation outcomes and introduction of new trial arms
Detailed Description:
From 2020 the Principal Investigators team has developed an innovative chatbot named Minimal AntiretRoViral INterference MARVIN for people with HIV The primary objectives with this master protocol are to 1 develop or adapt the MARVIN chatbots for different healthcare contexts through co-construction 2 evaluate the global usability of individual chatbots in their respective use scenarios with a small sample of research participants 3 evaluate the implementation and user outcomes eg fidelity appropriateness of individual chatbots in their respective use scenarios with a larger sample of research participants This includes also documentation of factors that inhibit or enhance the utilization of the chatbots and outcomes and 4 establish and evaluate through the previous objectives different partnerships with research participants and research team members to co-construct chatbots that will respond to their needs and encourage continued use of the tool
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None